| 08/17 | ENDO INTERNATIONAL : Enters Into Restructuring Support Agreement with Senior Secured Debth.. | PU |
| 08/17 | ENDO INTERNATIONAL PLC : Bankruptcy or Receivership, Change in Directors or Principal Offi.. | AQ |
| 08/16 | Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Str.. | PR |
| 08/10 | Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Ad.. | AQ |
| 08/09 | ENDO INTERNATIONAL : REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS - Form 8-K | PU |
| 08/09 | ENDO : Q2 Earnings Snapshot | AQ |
| 08/09 | ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 08/09 | Endo reports second-quarter 2022 financial results | PR |
| 08/08 | Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Ad.. | AQ |
| 07/28 | ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 07/15 | ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 07/15 | Quoin Pharmaceuticals and Endo Ventures Limited Enter Into Exclusive Distribution and S.. | AQ |
| 07/01 | ENDO INTERNATIONAL PLC : Notice of Delisting or Failure to Satisfy a Continued Listing Rul.. | AQ |
| 07/01 | Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor | PR |
| 07/01 | Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor | AQ |
| 07/01 | Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolytic.. | AQ |
| 06/30 | ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 06/13 | Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Tr.. | PR |
| 06/13 | TLC Announces TLC599 Agreement with Endo | AQ |
| 06/09 | ENDO INTERNATIONAL PLC : Submission of Matters to a Vote of Security Holders, Financial St.. | AQ |
| 06/09 | National Survey of Over 1,500 Men Shows More Than Half Were Unsure of How to Improve Th.. | PR |
| 05/06 | ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 05/05 | ENDO : Q1 Earnings Snapshot | AQ |
| 05/05 | Endo reports first-quarter 2022 financial results | PR |
| 05/05 | Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histol.. | PR |
| 05/03 | Endo Ventures acquires six injectable product candidates from Nevakar Injectables | AQ |
| 05/02 | ENDO INTERNATIONAL : Acquires Six Development-Stage, Ready-to-Use Injectable Product Candi.. | PU |
| 05/02 | ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 05/02 | Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Ne.. | PR |
| 05/02 | Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Ne.. | AQ |
| 05/02 | Nevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candid.. | AQ |
| 04/29 | ENDO INTERNATIONAL : Results of Operations and Financial Condition - Form 8-K | PU |
| 04/20 | Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judg.. | AQ |
| 04/12 | Endo to Announce First-Quarter 2022 Financial Results | PR |
| 03/30 | West Virginia reaches $26M settlement with opioid maker Endo | AQ |
| 03/28 | Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials | PR |
| 03/03 | Endo Launches New Living Our Values Program to Recognize Outstanding Team Members | PR |
| 03/02 | BUTT FIRST : Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostri.. | PR |
| 03/01 | ENDO : Q4 Earnings Snapshot | AQ |
| 03/01 | ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 03/01 | ENDO INTERNATIONAL : Q4 2021 Endo International plc Earnings Conference Call | PU |
| 02/28 | ENDO INTERNATIONAL : REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS - Form 8-.. | PU |
| 02/28 | Endo reports fourth-quarter and full-year 2021 financial results | PR |
| 02/11 | Endo Comments on Default Judgment on Liability in Tennessee State Court | PR |
| 02/07 | Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-M.. | PR |
| 01/25 | Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results | PR |
| 01/18 | Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims | PR |
| 01/17 | Paladin Labs Announces the Launch of Xydalba® (dalbavancin for injection) in Canada | AQ |
| 01/13 | Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Review.. | PR |
| 01/11 | Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients, Watching Ed.. | AQ |
| 01/11 | ENDO INTERNATIONAL : at J.P. Morgan Healthcare Conference | PU |
| 01/11 | ENDO INTERNATIONAL PLC : Regulation FD Disclosure (form 8-K) | AQ |
| 01/11 | Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Develop.. | PR |
| 01/10 | ENDO LAUNCHES NEW DUPUYTREN'S CONTRA : Watching Education Unfold | PR |
| 01/05 | Endo Launches First Generic Version of CUVPOSA (glycopyrrolate) Oral Solution | AQ |
| 01/04 | Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution | AQ |
| 01/04 | Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference | PR |
| 2021 | Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPR.. | AQ |
| 2021 | Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims | AQ |
| 2021 | Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPR.. | PR |
| 2021 | Endo Announces Favorable Final Ruling in California State Court Opioid Trial | PR |
| 2021 | ENDO INTERNATIONAL : Public Statement Against Use of Medicines for Capital Punishment | PU |
| 2021 | Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data Presented at the American .. | AQ |
| 2021 | Endo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) Injection | PR |
| 2021 | Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Prod.. | AQ |
| 2021 | Endo Announces Agreement with Premier to Supply VASOSTRICT (vasopressin injection, USP).. | AQ |
| 2021 | Endo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP.. | PR |
| 2021 | ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 2021 | Q3 2021 Endo International plc Earnings Conference Call | PU |
| 2021 | ENDO : Q3 Earnings Snapshot | AQ |
| 2021 | ENDO REPORTS THIRD-QUARTER 2021 FINANCIAL RESULTS AND RAISES 2021 FINANCIAL GUIDANCE - .. | PU |
| 2021 | ENDP Q3 2021 Slides | PU |
| 2021 | ENDO INTERNATIONAL PLC : Results of Operations and Financial Condition (form 8-K) | AQ |
| 2021 | Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance | PR |
| 2021 | ENDO INTERNATIONAL PLC : Change in Directors or Principal Officers (form 8-K) | AQ |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
